Page last updated: 2024-11-05

troglitazone and Adjuvant Arthritis

troglitazone has been researched along with Adjuvant Arthritis in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tseng, FJ1
Chia, WT1
Wang, CH1
Shyu, JF1
Gou, GH1
Shui, HA1
Sytwu, HK1
Pan, RY1
Weng, CF1
Kawahito, Y1
Kondo, M1
Tsubouchi, Y1
Hashiramoto, A1
Bishop-Bailey, D1
Inoue, K1
Kohno, M1
Yamada, R1
Hla, T1
Sano, H1

Other Studies

2 other studies available for troglitazone and Adjuvant Arthritis

ArticleYear
Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 36, Issue:3

    Topics: Acid Phosphatase; Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti

2015
15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.
    The Journal of clinical investigation, 2000, Volume: 106, Issue:2

    Topics: Animals; Apoptosis; Arthritis; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Chro

2000